Okay, let's tackle this question about unfractionated heparin. The user wants me to figure out which statement is incorrect. First, I need to recall the key points about unfractionated heparin. Heparin is an anticoagulant, right? It works by enhancing antithrombin III, which inhibits thrombin and other clotting factors.

So, the question is asking which statement is NOT true. Let's think about the common facts. UFH has a short half-life compared to low molecular weight heparins (LMWHs). It's monitored with aPTT, whereas LMWHs are usually dosed based on weight without routine monitoring. UFH can cause heparin-induced thrombocytopenia (HIT), which is a serious side effect. Also, UFH has a variable bioavailability when given subcutaneously, requiring more frequent monitoring.

Now, considering the options. Let's imagine possible distractors. For example, if an option says UFH is monitored with INR, that's wrong because INR is for warfarin. Another might say UFH has a predictable anticoagulant effect, which is incorrect because UFH's effect is variable and needs aPTT monitoring. Another incorrect statement could be that UFH is not associated with HIT, but that's false because HIT is a known complication. Also, if an option claims UFH is given orally, that's wrong since it's administered parenterally.

Wait, the correct answer is the one that's false. Let's structure each part. The core concept is about UFH's mechanism, monitoring, side effects, and administration. The correct answer would be the statement that contradicts these facts. For each wrong option, I need to explain why it's incorrect. For example, if an option states UFH is monitored with INR, then the explanation would clarify that aPTT is the correct monitoring parameter.

Clinical pearls: Remember that UFH requires aPTT monitoring, HIT is a risk, and it's given parenterally. Also, LMWHs don't need routine monitoring. High-yield fact: Don't monitor UFH with INR.

Putting it all together, the correct answer is the one that says something incorrect about UFH. Let's make sure each section is clear and concise, keeping explanations within the character limit.

**Core Concept** Unfractionated heparin (UFH) is a rapidly acting anticoagulant that enhances antithrombin III to inhibit thrombin and factor Xa. Its use requires careful monitoring due to variable bioavailability and dose-dependent effects.

**Why the Correct Answer is Right** The incorrect statement is likely related to monitoring parameters or administration route. For example, if an option claims UFH is monitored with INR (International Normalized Ratio), this is false. UFH anticoagulation is monitored via activated partial thromboplastin time (aPTT), whereas INR is specific to vitamin K antagonists like warfarin. UFH also has unpredictable bioavailability, necessitating frequent aPTT checks to adjust dosing.

**Why Each Wrong Option is Incorrect**
**Option A:** If it states UFH causes heparin-induced thrombocytopenia (HIT), this is correct. HIT is a well-documented immune-mediated complication of UFH.
**Option

✓ Correct Answer: A. It is a powerful anticoagulant only in vivo